1,280
Participants
Start Date
June 30, 2007
Primary Completion Date
December 31, 2009
Study Completion Date
January 31, 2010
Rivaroxaban (Xarelto, BAY59-7939)
Participants orally administered rivaroxaban 15 mg OD (CrCL \[creatinine clearance\] \>= 50 mL/min) or 10 mg OD (CrCL 30-49 mL/min)
Warfarin
Participants orally administered a warfarin potassium tablet (INR \[international normalized ratio\] target was 1.6-2.6 for patients \>70 years and 2.0-3.0 for patients \<70 years)
Rivaroxaban placebo
Participants orally administered a rivaroxaban placebo tablet
Warfarin placebo
Participants orally administered a warfarin placebo tablet (adjusted based upon sham INR values)
Kasugai
Nagoya
Nagoya
Nagoya
Nagoya
Nagoya
Okazaki
Goshogawara
Hirosaki
Hirosaki
Asahi
Funabashi
Imba
Matsudo
Matsudo
Yotsukaidō
Imabari
Matsuyama
Matsuyama
Matsuyama
Niihama
Saijō
Tōon
Fukui-shi
Chikushi-gun
Chikushino-shi
Chikushino-shi
Fukuoka
Fukuoka
Fukuoka
Fukuoka
Kasuga
Kasuga
Kitakyushu
Kitakyushu
Kurume
Ogōri
Yame
Yame
Kōriyama
Gifu
Ōgaki
Maebashi
Mebashi
Ōtake
Asahikawa
Chitose
Hakodate
Muroran
Otaru
Sapporo
Sapporo
Sapporo
Sapporo
Sapporo
Sapporo
Sapporo
Sapporo
Sapporo
Sunagawa
Tomakomai
Kobe
Kobe
Kobe
Higashiibaraki
Hitachi
Jōsō
Kasama
Moriya
Namegata
Toride
Kanazawa
Nomi
Hanamaki
Morioka
Marugame
Takamatsu
Izumi
Kagoshima
Atsugi
Fujisawa
Fujisawa
Kamakura
Kawasaki
Yokohama
Yokohama
Yokohama
Yokohama
Nangoku
Kumamoto
Kyoto
Uji
Kuwana
Sendai
Sendai
Sendai
Sendai
Sendai
Komoro
Matsumoto
Suwa
Nagasaki
Jōetsu
Nagaoka
Beppu
Beppu
Ōita
Ōita
Ōita
Ōita
Yufu
Kasaoka
Okayama
Okayama
Okinawa
Shimajiri
Daitō
Higashiosaka
Hirakata
Hirakata
Kawachi-Nagano
Kishiwada
Osaka
Osaka
Osaka
Osaka
Osaka
Osaka
Takatsuki
Toyonaka
Yao
Hanyū
Kasukage
Kitamoto
Tokorozawa
Tokorozawa
Wako
Kusatsu
Fujinomiya
Fukuroi
Hamamatsu
Hamamatsu
Iwata
Shimada
Shizuoka
Shizuoka
Shizuoka
Narutochō-mitsuishi
Tokushima
Edogawa-ku
Hachiōji
Higashikurume
Itabashi-ku
Itabashi-ku
Meguro-ku
Ōta-ku
Shibuya-ku
Shinagawa-ku
Shinjuku-ku
Tottori-shi
Toyama
Wakayama
Higashikawada
Shimonoseki
Shūnan
Lead Sponsor
Janssen R&D, L.L.C.
UNKNOWN
Bayer
INDUSTRY